Rachel Sanborn, M.D.

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Merck
    Topic:
    Funding for investigator-sponsored trial
    Date added:
    09/26/2022
    Date updated:
    05/24/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    BeiGene
    Topic:
    Steering Committee
    Date added:
    04/29/2024
    Date updated:
    05/24/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Gilead
    Topic:
    Advisory Board
    Date added:
    04/29/2024
    Date updated:
    05/24/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Targeted Oncology
    Topic:
    Advisory Board
    Date added:
    04/29/2024
    Date updated:
    05/24/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    G1 Therapeutics
    Topic:
    Advisory Board
    Date added:
    04/29/2024
    Date updated:
    05/24/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    GE HealthCare
    Topic:
    Advisory Board
    Date added:
    04/29/2024
    Date updated:
    05/24/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Amgen
    Topic:
    Advisory Board
    Date added:
    04/29/2024
    Date updated:
    05/24/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Illumina
    Topic:
    Educational Presentations
    Date added:
    04/29/2024
    Date updated:
    05/24/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    OncLive
    Topic:
    Educational Presentation
    Date added:
    04/29/2024
    Date updated:
    05/24/2025

Pages

Return to Best of ASCO 2025, Portland